跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MRESVIA DISPERSION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MRESVIA DISPERSION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
MRESVIA DISPERSION INYECTABLE EN JERINGA PRECARGADA
Moderna Biotech Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 12, 2024
Approval ID
e9532736c9471868
Company
Moderna Biotech Spain S.L.
Type
Standard
Approval Details
Approval Id
e9532736c9471868
Drug Cima Aemps Name
MRESVIA DISPERSION INYECTABLE EN JERINGA PRECARGADA
Register Number
1241849001
Holder Company Name
Moderna Biotech Spain S.L.
Marketing Company Name
Moderna Biotech Spain S.L.
Authorization Date
2024-09-12
Dosage Form
DISPERSIÓN INYECTABLE
Dose
50 µg
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Moderna Biotech Spain S.L.
Active Ingredients
GLICOPROTEINA F DEL VIRUS RESPIRATORIO SINCITIAL EN SU CONFORMACION PREFUSION, ARNM MONOCATENARIO PROTEGIDO EN EL EXTREMO 5′ QUE CODIFICA PARA
0,10 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 12, 2024
Approval ID
e9532736c9471868
Type
Standard
Back to CIMA-AEMPS Approvals
